-
Novel Combination Oncolytic Adenoviral Gene Therapy Armed with Dm-dNK and CD40L for Breast Cancer.
Author: Wang Q1, Yang M1, Zhang Y2, Zhong L3, Zheng X1.
Journal: Curr Gene Ther. 2019 Mar 6. doi: 10.2174/1566523219666190307094713. [Epub ahead of print]
-
Gene Therapy on the Road
Author: Feng YM1.
Journal: Curr Gene Ther. 2019 May 10. doi: 10.2174/1566523219999190426144513. [Epub ahead of print]
-
Novel p53 delivery systems in the treatment of head and neck cancer.
Author: Lu Y1, Wang H1.
Journal: Curr Gene Ther. 2019 May 10. doi: 10.2174/1566523219666190510120236. [Epub ahead of print]
-
Advances in liver-directed gene therapy for hepatocellular carcinoma by non-viral delivery systems.
Author: Ding B, Li T, Zhang J, Zhao L, Zhai G.
Journal: Curr Gene Ther. 2012 Apr 1;12(2):92-102.
-
Biodistribution and safety assessment of bladder cancer specific recombinant oncolytic adenovirus in subcutaneous xenografts tumor model in nude mice.
Author: Wang F, Wang Z, Tian H, Qi M, Zhai Z, Li S, Li R, Zhang H, Wang W, Fu S, Lu J, Rodriguez R, Guo Y, Zhou L.
Journal: Curr Gene Ther. 2012 Apr 1;12(2):67-76.
-
Current advances in vehicles for brain gene delivery.
Author: Zhang X, Zhao L, Wu J, Dong H, Xu F, Gong G, Hu Y.
Journal: Curr Gene Ther. 2012 Oct;12(5):423-36.
-
MicroRNAs and the Warburg Effect: new players in an old arena.
Author: Gao P, Sun L, He X, Cao Y, Zhang H.
Journal: Curr Gene Ther. 2012 Aug;12(4):285-91.
-
Equipping CAR-modified T cells with a brake to prevent chronic adverse effects.
Author: Wang W, Wang Y.
Journal: Curr Gene Ther. 2012 Dec;12(6):493-5.
